2.81
+0.07(+2.55%)
Currency In USD
| Previous Close | 2.74 |
| Open | 2.73 |
| Day High | 2.82 |
| Day Low | 2.71 |
| 52-Week High | 5.39 |
| 52-Week Low | 1.6 |
| Volume | 512,416 |
| Average Volume | 1.69M |
| Market Cap | 208.85M |
| PE | -1.86 |
| EPS | -1.51 |
| Moving Average 50 Days | 2.67 |
| Moving Average 200 Days | 3.01 |
| Change | 0.07 |
If you invested $1000 in Perspective Therapeutics, Inc. (CATX) 10 years ago, it would be worth $295.79 as of December 25, 2025 at a share price of $2.81. Whereas If you bought $1000 worth of Perspective Therapeutics, Inc. (CATX) shares 5 years ago, it would be worth $600.43 as of December 25, 2025 at a share price of $2.81.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Perspective Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Dec 18, 2025 12:00 PM GMT
SEATTLE, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announ
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the ASCO Gastrointestinal Cancers Symposium
GlobeNewswire Inc.
Dec 04, 2025 12:00 PM GMT
SEATTLE, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announ
Perspective Therapeutics to Participate in Upcoming December Conferences
GlobeNewswire Inc.
Nov 20, 2025 12:00 PM GMT
SEATTLE, Nov. 20, 2025 (GLOBE NEWSWIRE) -- November 20, 2025 – Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout t